Erdogan-Trinkaus Ipek bought ETON
January 12, 2026 · Form 4 insider transaction
Erdogan-Trinkaus Ipek bought 25,856 shares of Eton Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,856
Price
$0.00
Total value
N/A
InsiderErdogan-Trinkaus Ipek
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after149,734
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.; The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.